Search Results for: APP

2116 interactions involving APP - amyloid beta precursor protein found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
MEST mesoderm specific transcript
METAP2 methionyl aminopeptidase 2
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Methionine
  • Nitroxoline
  • 3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium
  • Fumagillin
  • D-Methionine
  • N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide
  • (2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide
  • tert-butanol
  • (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide
  • Ovalicin
  • PPI-2458
  • 5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID
  • 5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID
  • 2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID
  • 2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID
  • N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE
  • 3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID
  • TNP-470
METTL16 methyltransferase 16, RNA N6-adenosine
METTL25 methyltransferase like 25
METTL2B methyltransferase 2B, tRNA N3-cytidine
METTL8 methyltransferase 8, tRNA N3-cytidine
MICU1 mitochondrial calcium uptake 1
  • Mitochondrial calcium ion transport
  • Processing of SMDT1
MIER1 MIER1 transcriptional regulator
MITF melanocyte inducing transcription factor
  • SUMOylation of transcription factors
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Malignant melanoma
  • Ocular albinism; Ocular albinism, type I (OA1); Waardenburg syndrome, type II (WS2-OA)
  • Waardenburg syndrome (WS)
MKKS MKKS centrosomal shuttling protein
  • BBSome-mediated cargo-targeting to cilium
  • 46,XX disorders of sex development (Other), including: Mullerian aplasia and hyperandrogenism; McKusick-Kaufman syndrome
  • Bardet-Biedl syndrome (BBS)
MKNK1 MAPK interacting serine/threonine kinase 1
  • Spry regulation of FGF signaling
  • Fostamatinib
MLLT3 MLLT3 super elongation complex subunit
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Pre-transcription Events
  • RNA Polymerase II Transcription Elongation
MLLT6 MLLT6, PHD finger containing
MLX MAX dimerization protein MLX
  • ChREBP activates metabolic gene expression
  • ChREBP activates metabolic gene expression
MMGT1 membrane magnesium transporter 1
  • Miscellaneous transport and binding events
MMP12 matrix metallopeptidase 12
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Acetohydroxamic acid
  • Marimastat
  • CP-271485
  • PF-00356231
  • Batimastat
  • 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid
  • AE-941
  • (1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE
  • N-(biphenyl-4-ylsulfonyl)-D-leucine
  • CGS-27023
  • N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine
  • N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide
  • 2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide
  • N-oxo-2-(phenylsulfonylamino)ethanamide
  • N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID
  • N-[(4-methoxyphenyl)sulfonyl]-D-alanine
MND1 meiotic nuclear divisions 1
  • Meiotic recombination
MOB1A MOB kinase activator 1A
  • Signaling by Hippo
MOB1B MOB kinase activator 1B
  • Signaling by Hippo
MOB3A MOB kinase activator 3A

Page 54 out of 106 pages